Fed up with the low share price?, page-67

@Happytrades



Below is a drug which is going through clinical trials and is not in the market place


Race Oncology Ltd (RAC) is an Australian pharmaceutical company whose business model is to pursue and bring to market later stage assets, principally in the cancer field. The Company's first important asset is a chemotherapy drug, called Bisantrene, which was the subject of more than 40 phase II clinical studies
It basically has one asset only and yet its depressed share price is currently trading at over $2.80 with a market cap of $443 million

Now compare this to Starpharma which has a market cap of $385 million and has multiple drugs going through clinical trials with and without partners.......and.......a platform that can be applied to 75% of drugs that are currently being sold globally

I agree with most of the long term holders........Starpharma is way way way way under the odds in my opinion and shortly we may see the cream rise to the top


On another note.......there were 188,000 shares bought at auction last Friday and share price which had been trading most of the day around 90 cents.....surged 4.5 cents to finish day at 94.5 cents

Can we see a repeat today